Sujit K. Ghosh, Ph.D., is Professor of Statistics and Co-Director of Statistics Graduate Programs at NCSU. Dr. Ghosh's research focuses on Bayesian statistical inference and its application to biomedical and environmental research using modern computational tools such as Markov chain Monte Carlo (MCMC). He has directed the dissertation research of 25 PhD students.
Christopher Granger, M.D., is Professor of Medicine at Duke University and and Director of the Cardiac Care Unit at Duke University Medical Center. Dr. Granger's research interest is in large randomized clinical trials focusing on acute ischemic heart disease and heart failure. He has served in leadership roles on numerous high-profile CVD trials, and serves on the steering committees of several important CVD registries.
Jacqueline M. Hughes-Oliver, Ph.D., is Professor of Statistics at NCSU. Dr. Hughes-Oliver has made important contributions to statistical methods for drug discovery and environmental health and actively collaborates with scientists at GlaxoSmithKline and several biotechnology companies. She is the director of a large multidisciplinary project to develop statistical and computational methods to identify compounds that may be developed into medicines. Dr. Hughes-Oliver has directed over 10 doctoral dissertations.
Andrzej Kosinski, Ph.D., is Associate Professor of Biostatistics and Bioinformatics at Duke University. Dr. Kosinski joined DCRI after over a decade at the Department of Biostatistics in The Rollins School of Public Health of Emory University, where he supervised 2 doctoral students. He has extensive experience in clinical trials, having directed the data coordinating centers for several important studies. His statistical research is in evaluation of diagnostic tests, adjustment for misclassification of exposure, and outlier detection in multivariate data. He recently directed a PhD dissertation for 1 NCSU Statsitics student.
Wenbin Lu, Ph.D., is Associate Professor of Statistics at NCSU. Dr. Lu's research focuses on new methods for regression analysis of multivariate time-to-event data, including recurrent events, and on methods for model selection in the survival analysis. He is directing over 10 doctoral dissertations.
L. Kristin Newby, M.D., is Associate Professor of Medicine at Duke University, Co- Director of the Cardiac Care Unit, and Director of the Primary and Acute Cardiology Practice Group at Duke University Medical Center. She is an expert on the role of hormone replacement therapy for CVD prevention, and her research interests include risk stratification of ACS patients and use of protein biomarkers to stratify risk and guide therapy. She has also served as the coordinating center lead investigator for numerous DCRI studies.
